by June 26, 2019
It was only a few years ago that digital innovation at pharmaceutical companies was the province of tiny siloed innovation groups, churning out the odd companion app for a drug. These days, innovation is front and center, with big pharma acquiring, partnering and innovating in-house in all kinds of areas from digital therapeutics to remote clinical trials to connected drug delivery devices. And that’s not even mentioning the incredible transformative power of AI for drug development or pharma’s increasing presence as strategic investors in promising digital health companies.
The question is no longer, “Will pharma innovate?”; it’s “How is pharma innovating?”. In the month of July, we’ll take a closer look at the many answers to this question, as well as exploring what the changing face of pharma means for other healthcare stakeholders.